Sharechat Logo

Policy review lifts F&P Healthcare

Nick Stride

Friday 30th April 2004

Text too small?
Shares in Fisher & Paykel Healthcare jumped 30c on Tuesday after an analyst released a report highlighting a promising move in the US.

Goldman Sachs JB Were's Dennison Hambling reported the US government's Centers for Medicare and Medicaid Services (CMS) was reviewing its national coverage of obstructive sleep apnea (OSA) requiring continuous positive airway pressure (CPAP) therapy.

Healthcare is one of the main suppliers of CPAP equipment in the US market and stands to benefit significantly from any change in policy.

Policy requires polysomnography, or sleep tests, to be performed in a facility-based sleep-study laboratory. CMS is considering allowing diagnoses to be conducted in patients' homes using portable devices.

This would reduce waiting times, which could potentially lift industry growth rates by 400 basis points (4%) for the next three years, Mr Hambling said.

"If Healthcare were to benefit according to its current market share, this would lift its valuation by 42c."

CMS is an agency of the Department of Health and administers the US' federal health programmes.

According to its website nearly 40 million people are covered by Medicare and 33 million are eligible for Medicaid. Including with the State Children's Health Insurance Program the agency spent $US 429 billion in 2000.

It is expected to complete its review by October 8. The review was called for by a member of the advisory board of Resmed, a competing supplier of CPAP equipment. As Resmed would benefit from a policy change, that raises the possibility the agency might regard the need for change with some scepticism.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
FISHER & PAYKEL HEALTHCARE ANNOUNCES NEW NASAL PILLOWS MASK AT INVESTOR DAY
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins